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Abstract
Background: The incidence of community-acquired pneumonia (CAP) almost triples for older adults aged 65 years or 
older. In Canada, CAP is a leading cause of hospital admissions and mortality. Although CAP is very prevalent, 
complications due to CAP may be reduced with the pneumococcal polysaccharide vaccine (PPV). The purpose of this 
study was to identify predictors of pneumococcal vaccination among community-dwelling older adults with clinically 
diagnosed CAP.
Methods: A telephone survey was used to collect detailed information from adults aged 60 years and older with 
clinically diagnosed CAP. This was a community wide study with participants being recruited from all radiology clinics 
in one Ontario community.
Results: The most important predictors of pneumococcal vaccination among older adults included: getting an 
influenza vaccine within the past year (OR 14.5, 95% CI 4.27 to 49.0); at least weekly contact with a friend (OR 3.97, 95% 
CI 1.71 to 9.24); having one or more co-morbidities/chronic conditions (OR 3.64, 95% CI 1.60 to 8.28); being 70 years of 
age or older (OR 2.56, 95% CI 1.21 to 5.40); having health problems that limited physical activities (OR 5.37, 95% CI 1.49 
to 19.3); having little or no bodily pain (OR 2.90, 95% CI 1.25 to 6.73); and reporting having spiritual values or religious 
faith (OR 3.47, 95% CI 1.03 to 11.67).
Conclusions: A wide range of factors, including demographic, co-morbidity, quality of life, social support and lifestyle 
were found to be associated with pneumococcal vaccination status among older adults with clinically diagnosed CAP. 
The findings from this study could inform future pneumococcal immunization strategies by identifying individuals who 
are least likely to receive the PPV.
Background
Community-acquired pneumonia (CAP) refers to pneu-
monia acquired outside of hospitals or extended-care
facilities [1]. In Canada, CAP poses a considerable threat
to the health of older adults and the incidence of CAP
almost triples among those aged 65 years or older [2].
With the pending demographic influx of seniors, the
prevalence of CAP is expected to substantially increase,
resulting in a greater burden for older adults, their care-
givers and the health care system [3]. CAP is a leading
cause of hospital admissions and mortality in Canada
[2,4,5] and with increasing age, there is a corresponding
increase in morbidity and loss of independence for older
adults [6,7]. Furthermore, case fatality rates of pneumo-
nia with invasive pneumococcal disease increase sharply
from 20% (for person 65 years or older) to 40% (for per-
sons 85 years or older) [8]. Seniors with cardiopulmonary
disease, poor functional status (such as limitations with
activities of daily living), weight loss or recent changes in
weight are at increased risk for CAP [9].
The most common causative pathogen worldwide of
CAP is Streptococcus Pneumoniae, accounting for
approximately 30-50% of all cases [10]. The pneumococ-
cal polysaccharide vaccine (PPV-23) immunizes against
23 strains of the pneumococcus bacteria [11]. PPV is 50-
80% effective in the prevention of invasive pneumococcal
disease among immunocompetent patients [11-13].
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While the efficacy of the pneumococcal vaccine in pre-
venting pneumonia remains inconclusive, [12,14-16]
there is evidence that administration of the vaccine can
play a critical role in reducing the severity of the disease
among older adults [15].
Despite recommendations for uptake of PPV in seniors
and a target goal of 80% immunization rate among adults
aged 65 years or older by the year 2010 in Canada, [11-
13,17] immunization rates remain low with only 42% of
Canadians over 65 years of age reported being vaccinated
[13,17,18]. In order to further understand PPV uptake in
Canada, where the vaccine is publically funded, we
explored the predictors for pneumococcal vaccination
among community-dwelling older adults with clinically
diagnosed CAP.
Methods
The Community Acquired Pneumonia Impact Study
(CAPIS) was a mixed methods, community-based study
designed to assess the impact of CAP on older adults and
their family caregivers. This manuscript reports the find-
ings from the quantitative data, specifically focusing on
predictors of pneumococcal vaccination among older
adults having a clinical diagnosis of CAP. Other qualita-
tive and quantitative findings are reported elsewhere
[19,20].
Setting
This study was conducted in Brant County, Ontario, a
mix of urban and rural settings which includes the city of
Brantford and the amalgamated County of Brant (com-
prised of eight towns and villages). The population of
Brant County at the time of data collection was 118,485
with 14% of the population aged 65 years and older. Brant
County was selected for this community-based study
because of its moderate size and population demograph-
ics. The population of Brant County is predominantly
English-speaking, with 86% reporting English as a first
language. There were two major community hospitals,
eight radiology centers and approximately 80 family phy-
sicians at the time of the study.
Recruitment
Study participants were recruited over a 15 month period
at the eight x-ray facilities in Brant County. Eligibility cri-
teria included being clinically diagnosed with CAP by a
family or emergency room physician, being 60 years of
age or older, living in the community (Brant County), pre-
senting for a chest x-ray at one of the community or hos-
pital radiology centres, speaking English, and obtaining
informed consent. Exclusion criteria included: cognitive
impairment and having hospital or nursing home
acquired pneumonia. In order to preserve the health of
the participants and prevent participant-burden, x-ray
technicians were trained to recruit participants at the
time of their x-ray and a trained interviewer telephoned
t h e  p a r t i c i p a n t s  f o u r  w e e k s  l a t e r .  E t h i c s  a p p r o v a l  w a s
obtained from McMaster University and the Brant Com-
munity Health Care System.
Data Collection
The interviewer collected detailed information including:
demographic characteristics (gender, age, marital status,
living arrangements (i.e. number, ages and relationships
of people living in the household; owning or renting; type
of dwelling), cultural background (i.e. the ethnic or cul-
tural group most identified as representing their heri-
tage), level of education (categories from none to a
university graduate degree), household income (total
household income before taxes and deductions in $20 k
increments), perceived level of social status (as measured
by the MacArthur Scale of Subjective Social Status),
employment history (whether currently employed; main
occupation when employed); co-morbidities (e.g. aller-
gies, asthma, chronic bronchitis, diabetes, emphysema,
heart disease, cancer and liver disease); lifestyle (e.g.
immunizations (if ever received the influenza and pneu-
monia vaccines; and the timing either < 1 year ago; 1 to 2
years ago; more than 2 years ago), having a family physi-
cian, smoking status, exposure to second hand smoke,
alcohol consumption (ever in the past 12 months), own-
ership of pets, nutrition (frequency skipping meals, num-
ber of servings of fruits, vegetables, milk products, meal
replacements/supplements; difficulty chewing or swal-
lowing; self perceived appetite), spiritual values (rating of
how much spiritual values or religious faith plays a role in
their life), overall happiness (rating from very unhappy to
very happy); quality of life (using the Short-Form-8
Health Survey (SF-8) to collect information on overall
health, activity limitation because of health problems, dif-
ficulty doing usual daily activities because of physical
health, amount of bodily pain, level of energy, limitations
of social activities and activities due to personal or emo-
tional problems); functional status (measured using the
10-item Modified Barthel Index which includes groom-
ing, dressing, feeding oneself, transferring from one's bed
to a chair, bathing, toilet use, bladder control, bowel con-
trol, mobility, climbing stairs); instrumental activities of
daily living scale (measured using the 8-item Instrumen-
tal Activities of Daily Living Scale developed Lawton
which includes items on meal preparation, mobility
beyond short distances, shopping, phone calling, doing
laundry, doing household work or handymen work, tak-
ing one's medication and money managing); and social
support (numbers and types of family relatives, friends,
distance to these contacts, frequency of contact, involve-
ment in social and religious networks). Data collection
ended March 2004.Krueger et al. BMC Geriatrics 2010, 10:44
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Data analysis
The dependent variable was self reported pneumococcal
vaccination status prior to receiving a clinical diagnosis of
CAP. The dichotomous outcome variable was created
based on participant responses, namely, "ever vaccinated"
and "never vaccinated". Based on the literature and clini-
cal experience, two investigators (PK and ML) reviewed
the questionnaire for potential predictors to include in
the analysis. The potential predictor variables included
the above listed demographic characteristics, co-morbid-
ities, lifestyle, quality of life, functional status, instrumen-
tal activities of daily living, and social support variables.
Data from the telephone interviews were entered into
and analyzed using SPSS 17.0 (SPSS Inc., Chicago IL).
Descriptive statistics were computed for all variables,
including frequency counts, and percentages for categori-
cal variables, or means and standard deviations for con-
tinuous variables. For categorical variables, we used the
chi-squared test, or when appropriate, Fisher's exact test
to determine the significance of potential predictor vari-
ables. In addition, unadjusted odd ratios (ORs) and 95%
confidence intervals (CIs) are reported for each potential
predictor of pneumococcal vaccination. T-tests were
used to compare continuous variables between the vacci-
nated and non-vaccinated patients.
A logistic regression analysis was used to identify the
best predictors of pneumococcal vaccination status from
those variables which had a statistically significant associ-
ation in the above bivariate analyses or were considered
by the investigators to be theoretically significant. A for-
ward selection process was used whereby non-significant
variables were removed from the model one at a time.
The parameter estimates were reviewed at each step to
assess whether the eliminated variable should be kept in
the model to control for confounding. Adjusted ORs and
corresponding 95% CIs are reported for each variable in
the final logistic regression model. The goodness of fit of
the logistic regression model was assessed using rho-
square statistic [21]. A rho-square value between 0.20 and
0.40 suggests a very good fit of the model. The Cox and
Snell (R2) and Nagelkerke (R2) statistics are also reported
as estimates of the proportion of variance explained by
the final model. A probability level of < .05 was used to
determine statistical significance.
Results
Sample Characteristics
Forty-four potentially eligible patients refused consent to
participate and therefore no information was available for
these individuals. Of those who initially agreed to partici-
pate, 86% completed the telephone interview. The reason
for declining was that the patients simply did not want to
participate. Of the 195 participants, 95 had x-ray con-
firmed CAP, and 185 reported on their pneumococcal
vaccination status. Among these participants: 62% were
female; 66% were aged 70 years or older (mean 72.7 years,
standard deviation 6.7); 62% were married or common-
law; 71% lived with others; 76% owned their homes; 54%
completed high school; 68% earned a household income
of $20,000 or more; and 94% had children.
Bivariate Analysis
A total of 58 variables were identified a priori from the
telephone interview data as potential predictors of pneu-
mococcal vaccination status. Of these 58 variables, 19
were included in the logistic regression analysis based on
either their statistical or theoretical significance (Table 1).
Multivariable Analysis
The 19 variables shown in Table 1 were entered into a
logistic regression analysis. The final logistic regression
model included seven variables (Table 2): getting an influ-
enza vaccine within the past year (OR 14.5, 95% CI 4.27
to 49.0); at least weekly contact with a friend (OR 3.97,
95% CI 1.71 to 9.24); having one or more co-morbidities/
chronic conditions (OR 3.64, 95% CI 1.60 to 8.28); being
70 years of age or older (OR 2.56, 95% CI 1.21 to 5.40);
having health problems that limited physical activities
(OR 5.37, 95% CI 1.49 to 19.3); having little or no bodily
pain (OR 2.90, 95% CI 1.25 to 6.73); and reporting having
spiritual values or religious faith (OR 3.47, 95% CI 1.03 to
11.67). The final logistic regression model statistics are
reported in Table 2.
Discussion
From our dataset, we identified seven important predic-
tors of pneumococcal vaccination. Those who reported
getting an influenza vaccine within the past year were
more likely to report having received the pneumococcal
vaccine than those who had not. Our results differ from
those of Al-Sukhni et al. who did not find a statistically
significant association between regular annual receipt of
the influenza vaccine and the likelihood of pneumococcal
vaccination (OR 0.90; 95% CI 0.45-1.79; p-value = 0.75)
[13]. The authors, however, reported that most partici-
pants (59%, 92/156) reported receiving the PPV at the
same time as the influenza vaccine [13]. The timing of the
vaccine (and therefore the opportunity to receive PPV)
may be related to the influenza vaccine as a predictor for
pneumococcal vaccination.
Older adults who reported chatting or doing something
with a friend at least once/week were more likely to
report having received the pneumococcal vaccine. This
finding is in keeping with what may be reasonably
expected. A study by Madhavan et al. assessed predictors
of influenza and pneumonia vaccination among rural
senior adults in the United Kingdom. The authors found
that knowing someone with pneumonia was the strongestKrueger et al. BMC Geriatrics 2010, 10:44
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Table 1: Potential predictors of pneumococcal vaccination among older adults (aged 60 years of age and older) with 
clinically diagnosed1 community acquired pneumonia (n = 185).
Pneumococcal Vaccination Status2
Potential Predictor Variables Ever Vaccinated
(n = 102)
Never Vaccinated
(n = 83)
P-value3 Odds Ratio4 95% CI
Demographic Variables
Participant's age (n = 183):
60 to 69 27 (42.9) 36 (57.1) 1.00 -
70 to 90 75 (62.5) 45 (37.5) 0.011 2.22 (1.19, 4.14)
Co-morbidities
Reported health condition (asthma) (n = 185):
No 84 (51.9) 78 (48.1) 1.00 -
Yes 18 (78.3) 5 (21.7) 0.017 3.34 (1.18, 9.44)
Reported health condition (chronic bronchitis) 
(n = 185):
No 77 (52.0) 71 (48.0) 1.00 -
Yes 25 (67.6) 12 (32.4) 0.089 1.92 (0.90, 4.11)
Reported health condition (diabetes) (n = 185):
No 85 (52.8) 76 (47.2) 1.00 -
Yes 17 (70.8) 7 (29.2) 0.097 2.17 (0.85, 5.52)
Reported health condition (emphysema) (n = 185):
No 90 (52.3) 82 (47.7) 1.00 -
Yes 12 (92.3) 1 (7.7) 0.0075 10.93 (1.39, 85.9)
Reported health condition (congestive heart 
failure) (n = 185):
No 93 (53.8) 80 (46.2) 1.00 -
Yes 9 (75.0) 3 (25.0) 0.152 2.58 (0.68, 9.86)
None of the above health conditions (n = 185):
Had none 21 (41.2) 30 (58.8) 1.00 -
Had at least one 81 (60.4) 53 (39.6) 0.019 2.18 (1.13, 4.21)
Lifestyle
Most recent influenza vaccine (n = 185):
One year or ore/never 4 (15.4) 22 (84.6) 1.00 -
Less than one year ago 98 (61.6) 61 (38.4) <0.001 8.84 (2.91, 26.9)
Before illness, how often did the
participant skip meals (n = 185):
Sometimes/often/daily 13 (36.1) 23 (63.9) 1.00 -
Never/rarely 89 (59.7) 60 (40.3) 0.011 2.62 (1.23, 5.58)Krueger et al. BMC Geriatrics 2010, 10:44
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How much does spiritual values or religious
faith play a role in life (n = 184):
None 7 (36.8) 12 (63.2) 1.00 -
Great deal to little 95 (57.6) 70 (42.4) 0.085 2.33 (0.87, 6.21)
Quality of life (SF-8) ratings before illness
Overall rating of health (n = 185):
Excel/very good/good 84 (53.2) 74 (46.8) 1.00 -
Fair/poor/very poor 18 (66.7) 9 (33.3) 0.192 1.76 (0.75, 4.16)
Before illness, how much did the participant's
health problems limit your usual activities
(n = 185):
Somewhat to not at all 82 (51.3) 78 (48.8) 1.00 -
Quite a lot/couldn't do 20 (80.0) 2 (20.0) 0.007 3.81 (1.36, 10.6)
How much does the participant have difficulty 
doing
usual daily activities because of physical health
 (n = 185):
Somewhat to not at all 88 (53.0) 78 (47.0) 1.00 -
Quite a lot/couldn't do 14 (73.7) 5 (26.3) 0.086 2.48 (0.86, 7.20)
How much bodily pain does the participant have 
(n = 184):
Mod/severe/very severe 54 (65.1) 25 (24.8) 1.00 -
None/very mild/mild 76 (75.2) 29 (34.9) 0.131 1.63 (0.86, 3.10)
How much energy does the participant have 
(n = 185):
Very much/a lot/some 91 (52.6) 82 (47.4) 1.00 -
A little/none 11 (91.7) 1 (8.3) 0.0135 9.91 (1.25, 78.5)
Functional Status (before illness)
Barthel 10-item ADL score (n = 184):
20 78 (52.0) 72 (48.0) 1.00 -
9 to 196 23 (67.6) 11 (32.4) 0.098 1.93 (0.88, 4.24)
Social support
Does the participant have sister(s) and/or 
brother(s) (n = 184):
Yes 72 (52.2) 66 (47.8) 1.00 -
No 30 (65.2) 16 (34.8) 0.123 1.72 (0.86, 3.44)
Distance to the participant's nearest sibling 
(n = 122):
Within Brant 22 (40.7) 32 (59.3) 1.00 -
Outside Brant 39 (57.4) 29 (42.6) 0.068 1.96 (0.95, 4.04)
Table 1: Potential predictors of pneumococcal vaccination among older adults (aged 60 years of age and older) with 
clinically diagnosed1 community acquired pneumonia (n = 185). (Continued)Krueger et al. BMC Geriatrics 2010, 10:44
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predictor for the pneumonia vaccination in rural senior
adults (p = 0.007) [22]. Older adults tend to talk about
their health and a discussion about influenza and or
pneumonia could prompt them to make an immunization
appointment with their family physician.
Older adults with one or more co-morbidities were also
more likely to report having received the pneumococcal
vaccine. A likely explanation for co-morbidities as a pre-
dictor for pneumococcal vaccination is that persons with
chronic conditions are more likely to access health care
services more frequently, allowing for more opportunities
to engage with health care practitioners. The evidence
related to the role of practitioners and pneumococcal
vaccination rates, however, is conflicting. Stehr-Green et
al. identified a recommendation by a health care provider
as the most important predictor of PPV immunization
among older adults [23]. In a study based in the same
region as this study (Brantford, Ontario) Krueger et al.
found that over half of family and ER physicians surveyed
reported CAP to be a very important health concern for
their practices [24]. In contrast, however, a study examin-
ing the impact of public vaccination programs in Ontario
found that more than 90% of unvaccinated respondents
reported seeing a physician at least once in the previous
year, indicating a missed opportunity for vaccination [13].
The authors suggest that this missed opportunity may be
related to physicians' on-going uncertainty about the
effectiveness of the vaccine.
O l d e r  s t u d y  p a r t i c i p a n t s  w e r e  m o r e  l i k e l y  t o  r e p o r t
having received the pneumococcal vaccine. This finding
is also in keeping with what may be reasonably expected.
Since the highest incidence of pneumonia occurs among
people > 85 years of age (81 cases per 100,000) in Canada
[14], it is more likely that these older patients would be
targeted for immunizations by family physicians. Simi-
larly, older adults who identified that their health prob-
l e m s  ( p r i o r  t o  t h e i r  b o u t  o f  p n e u m o n i a )  l i m i t e d  t h e i r
usual activities a lot, or prevented them from doing phys-
ical activities, were more likely to report having received
the pneumococcal vaccine. Again, this could be due to a
greater likelihood or frequency of contact with their fam-
ily physicians.
The finding that older adults with mild to no bodily
pain are more likely to have received the pneumococcal
vaccine than those with more severe pain may be related
to their ability to access health care services. Although
few studies have examined the relationship between
bodily pain and vaccination status, a study by Groenwold
et al. identified bodily pain as a potential unmeasured
confounder for immunizations, specifically using the
influenza vaccine as an example [25]. The authors found
bodily pain to be inversely related to vaccination status.
Further research is needed to understand the relationship
between bodily pain and the likelihood of immunization
[25]. Although somewhat speculative, those with less
pain may have less difficulty accessing their family physi-
cian or immunization clinic.
The finding that older adults who reported having spir-
itual values or religious faith was an important predictor
of pneumococcal vaccination is interesting. Again,
although speculative, this finding could be related to
social networking. Those who go to church or attend reli-
gious outings may be advised to get their immunizations
to avoid illness, or have greater opportunity for talking
about immunizations than those who do not have this
type of social networking. While the relationship
between spiritual values and/or religion and vaccination
status has not been explored in-depth in the literature
[26], some studies have demonstrated a positive relation-
How often in the last 6 months has the participant
seen or spoken with above relatives on the phone 
(n = 184):
Less than once/week 4 (30.8) 9 (69.2) 1.00 -
At least once/week 98 (57.3) 73 (42.7) 0.063 3.02 (0.90, 10.2)
How often in the last 6 months participant had a
chat or did something with a friend (n = 184):
Less than once/week 16 (37.2) 27 (62.8) 1.00 -
At least once/week 86 (61.0) 55 (39.0) 0.006 2.64 (1.30, 5.34)
1All participants sent for chest x-ray by physicians to rule out/confirm clinically suspected CAP.
2Self reported.
3Chi-square test.
4Unadjusted odds ratios.
5Fisher exact test.
6One participant had a score of 9, all others in this category scored either 18 or 19.
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Table 2: Logistic regression of the most important predictors of pneumococcal vaccination among older adults with 
clinically diagnosed community-acquired pneumonia and sent for confirmatory x-rays (n = 1811).
Predictors of Pneumococcal Vaccination Adjusted Odds Ratio2 95% Confidence Interval
Most recent influenza vaccine:
One year or more/never 1.00 -
Less than one year ago 14.46 (4.27, 49.0)
How often in the last 6 months participant had a chat or did something with a 
friend:
Less than once/week 1.00 -
At least once/week 3.97 (1.71, 9.24)
Reported having health conditions in list3:
Reported none 1.00 -
Reported at least one 3.64 (1.60, 8.28)
Participant's age:
60 to 69 1.00 -
70 to 90 2.56 (1.21, 5.40)
Before illness, how much did your health problems limit your usual activities4:
Somewhat, very little, not at all 1.00 -
Quite a lot, could not do physical activities 5.37 (1.49, 19.31)
Amount of bodily pain4:
Mod/severe/very severe 1.00 -
None/very mild/mild 2.90 (1.25, 6.73)
How much spiritual values or religious faith plays a role in life:
None 1.00 -
Great deal to little 3.47 (1.03, 11.67)
Final Logistic Regression Model Statistics:
Rho-square = 0.25 (pseudo R2, values between 0.2 and 0.4 suggest a very good fit)
Cox & Snell R-square = .292; Nagelkerke R-square = .391 (i.e. between 29.2% and 39.1% of variance is explained by this model)
Hosmer and Lemeshow Goodness-of-Fit test = 0.948 (values greater than 0.25 indicate good fit)
74.6% correctly classified
1Four of the 185 (2.2%) participants had missing values for one or more of the variables included in the final model.
2Odds ratios for categorical variables represent comparisons with the referent group (OR = 1.00) after adjustment for all other variables in the 
model. An odds ratio greater than one indicates increased likelihood for pneumococcal vaccination. For example, participants aged 70 and 
older were 2.56 times more likely to report receiving the pneumococcal vaccination than participants 60 to 69 years of age (after adjusting 
for all other variables in the model).
3List included: food allergies, other allergies, asthma, chronic bronchitis, diabetes, emphysema, heart disease, congestive heart failure, cancer, 
liver disease, kidney disease, ever received a transplant, taking immunosuppressant drugs.
4Question from SF-8.Krueger et al. BMC Geriatrics 2010, 10:44
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ship between religion and health promoting behaviors
such as healthy eating habit [27].
Strengths of this study include it being a community-
based study that attempted to recruit all older adults who
were sent for a chest x-ray to confirm/rule out CAP. In
addition, we had a comprehensive data set that allowed us
to explore the association between a wide range of demo-
graphic, health, lifestyle, quality of life, functional status,
and social support variables and whether or not commu-
nity dwelling older adults received the pneumococcal
vaccine. There are several potential limitations of this
study. The first is that we only recruited older adults who
went for chest x-rays. We therefore missed those who
were treated for CAP by their physicians but were not
sent for chest x-rays or who were sent but did not go.
Self-reported immunization status is another potential
limitation. The literature would suggest that the sensitiv-
ity of self reported pneumococcal vaccination status is
v e r y  g o o d  b u t  t h e r e  i s  m o r e  v a r i a b i l i t y  w i t h  r e p o r t e d
specificity. However, one potential reason for the variabil-
ity in specificity is the validity of the source of the com-
parison data (i.e. medical charts). This is particularly
important in Ontario where a relatively high percentage
of the population are without a family physician and
where older adults have easy access to community immu-
nization clinics outside family physician practices
(notices regarding immunization would not be sent to
family physicians). The inaccuracy of using medical
charts could therefore account for some of the variability
in specificity noted in the literature. Sample size was also
a limitation of this study, resulting in large confidence
intervals. Given the large number of potential predictor
variables and the relatively small sample size, another
limitation is the chance for Type I error. In defense of
this, however, we restricted our analyses to only include
meaningful variables that were chosen a priori and our
multivariate modeling fulfilled the requirement (1 vari-
able for 10 outcome events) for having reliable parameter
estimates. Since this study was done in only one relatively
homogeneous community, the generalizability of the
findings is another potential limitation. Although we
expect the accuracy of the information collected from
study participants to be very good, based on the use of
reliable and valid instruments, some degree of random
error should be expected in studies that collect self
reported data retrospectively. However, we don't suspect
that recall bias is a weakness of this study. And finally, our
definition of CAP was clinically diagnosed CAP versus x-
ray confirmed CAP. The decision to use clinically diag-
nosed CAP versus x-ray confirmed CAP was based on
there being no important differences in the characteris-
tics or outcomes of those clinically diagnosed versus
those with a positive chest x-ray; the fact that a large per-
centage of physicians do not send their patients for chest
x-rays; and to increase the sample size for this analysis.
Conclusions
In conclusion, this study identified a wide range of fac-
tors, including demographic (age), co-morbidity (having
at least one health condition; amount of bodily pain),
q u a l i t y  o f  l i f e  ( t h e  e x t e n t  t h a t  h e a l t h  p r o b l e m s  l i m i t ed
usual activities), social support (frequency chatting or
doing something with a friend) and lifestyle (recent influ-
enza immunization; and the amount that spiritual values
or religious faith played a role in life) to be associated
with pneumococcal vaccination status among older
adults with clinically diagnosed CAP. CAP is a relatively
common infection among community-dwelling elderly.
Although there are identified co-morbidity risk factors
for CAP, such as chronic lung disease, one of the most
important is age with the "older" elderly being at highest
risk. Because the risk of invasive pneumococcal disease
increases in this group, for which there is excellent evi-
dence that the vaccine is effective, from a health policy
perspective this is indeed the group that should be tar-
geted for pneumococcal immunization. The findings of
this study, by helping to delineate the likelihood of receiv-
ing the vaccine, identify factors that need to be consid-
ered when targeting vaccine to the "low-uptake" elderly.
Therefore, the findings from this study could inform
future pneumococcal immunization strategies in Canada
by identifying those individuals who are least likely to
receive the PPV.
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